CTRI/2021/02/031395
Recruiting
Phase 1
A randomized controlled clinical study to evaluate the efficacy of madhu kumari lepa in management of periorbital hyperpigmentation
purva verma self0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Health Condition 1: L80-L99- Other disorders of the skin and subcutaneous tissue
- Sponsor
- purva verma self
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.subjects diagnosed with periorbital hyperpigmentation will be included
- •2\.subjects of age group 21 to 50 years will be included irrespective of their gender ,religion,and socio economic status
- •3\.subjects who are willing to participate in the study
- •4\.subjects with periorbital hyperpigmentation caused due to constitutional causes
Exclusion Criteria
- •1\.subjects taking photosensitizing drugs like NASIDS,anti \-histamines,oral contraceptives,sulphonamides etc
- •2\.Chloasma/melasma,post \-inflammatory hyperpigmentation will be excluded
- •3\.smoking ,alcoholism
- •5\.subjects suffering from any other systemic illness
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1
To study the effect of Trayushanadi syrup and Bharangi Syrup in the management of Pratishyaya in children age group 3 to 6 years.Health Condition 1: J00- Acute nasopharyngitis [common cold]CTRI/2024/02/062317PDEAS College of Ayurved And Research Centre Nigdi Pune
Not yet recruiting
Phase 2
Effect of deodarubaladi tail matra basti and karpasasthyadi tail matra basti in patients of lower back pain.Health Condition 1: M199- Osteoarthritis, unspecified siteCTRI/2023/04/051809Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Dharmartha Rugnalaya Rasta Peth Pune 11
Not yet recruiting
Phase 3
A clinical trial to study the effect of Agnimukha Churna in patients with Udavartini Yoni Vyapad (Primary Dysmenorrhea) & compare the efficacy of this drug with Rajahpravartini Vati .CTRI/2023/12/060751Chinmayi M S
Recruiting
Phase 2
Role of Dadimadi Avaleha in treatment of Sickle cell anaemiaCTRI/2020/01/022912Department of Kaumarbhritya
Not yet recruiting
Phase 2
Effect of Dashmuladi Kashaya & Haritaki Kashaya in the management of Tundikeri(chronic tonsillitis) in children.Health Condition 1: J350- Chronic tonsillitis and adenoiditisCTRI/2024/02/062968Dr Ashwini Ashokrao Patil